{"id":821116,"date":"2025-03-04T07:07:22","date_gmt":"2025-03-04T12:07:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/"},"modified":"2025-03-04T07:07:22","modified_gmt":"2025-03-04T12:07:22","slug":"voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/","title":{"rendered":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LEXINGTON, Mass., March  04, 2025  (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2024 financial and operating results after market close on Tuesday, March 11, 2025. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET.<\/p>\n<p align=\"left\">A live webcast of the call will be available on the Investors section of the Voyager website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cn-Ue1jPtmYeEu4zY97TXv-f24FD404dQeBYXEC1utoZXqB-tfvo3W_yC9l41wBnqhjbXD5OS6xs7XwPqBXyDxw_7S9jZKgSJbg7mKK1nvq-IsJu5JAXiHFMzQHRTDkW\" rel=\"nofollow\" target=\"_blank\">ir.voyagertherapeutics.com<\/a>, and a replay of the call will be available at the same link approximately two hours after its completion. The replay will be available for at least 30 days following the conclusion of the call.<\/p>\n<p>\n        <strong>About\u00a0Voyager Therapeutics<\/strong><br \/>\n        <br \/>Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of \u2013 and ultimately cure \u2013 neurological diseases. Our pipeline includes programs for Alzheimer\u2019s disease, amyotrophic lateral sclerosis (ALS), Parkinson\u2019s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER\u2122 AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease;\u00a0Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QwqhzB6O3jpqVrtuIJAmViafgLV3MVHocpR3e0LaVGdW5c621EEBzQFUQIo1uhnJSTcmI6fyH2rUI2rylVcFmn7YxI5biz2LHNpR3RpHDVww04wy6vPNHteRJEuRMuIt\" rel=\"nofollow\" target=\"_blank\">www.voyagertherapeutics.com<\/a>.<\/p>\n<p>\n        <em>Voyager Therapeutics<\/em><br \/>\n        <sup><br \/>\n          <em>\u00ae<\/em><br \/>\n        <\/sup><br \/>\n        <em>\u00a0is a registered trademark, and TRACER\u2122 is a trademark, of\u00a0Voyager Therapeutics, Inc.\u00a0<\/em>\n      <\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Trista Morrison, NACD.DC,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1b3LF57IlrNtE3zNMhAOKRRYQywA89eI14GUog8KzKQzEyTixaVnqXHhmW35cqyb7pMgm9QjT0LAK3zfK3FIsZHa4sosCCEgZYFPjlTpM4_i31HgyP1Q_cGGSNcC36fiWez7Pojlc0SZ8pCze9GmPpQ9YINy_p7m5cZNyYAKUxmt9FoHUjifUh6pNIBsIniDRJh5rAkZVluoVTm63Utqz2UPR3QOgieN6nwR0cVEpnLVegnCsBe4Ofa3vq-3oSrpVT5ldIK9PrZxk96wX4Iaew==\" rel=\"nofollow\" target=\"_blank\">tmorrison@vygr.com<\/a><br \/>Media:\u00a0Brooke Shenkin,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YJyc3Pg9H0MHImi2PL5TUFq83MzXRdC0SCC8uJ-9onG-VRc-2fk09ErYOzHmDNqcYI0Cz5hGPm6Egt4NtbXf9RDihQ5PHaJuc_zu_zJPI_doaTKXCT6GN0RB2tpMGarY_m_MiAA5I4Mi4KWnvc2SC9-_5Tto4ArDmxXwQaQyYrZR7E76TeaAYvmw2uhTkPStXgRcANy__QSNAYTdlS7_rVkUo7HP-xBo7CmtYHk2DSNVW9rD0GDHaXJEfHN3p9Cw50NHFR_YGWoE2NjYGd2CgA==\" rel=\"nofollow\" target=\"_blank\">brooke@scientpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzRiNzEzOTAtMzBmNC00NGRhLWExZjQtN2NmYWQzMTE1ZmM5LTEwMzA0MTM=\/tiny\/Voyager-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2024 financial and operating results after market close on Tuesday, March 11, 2025. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET. A live webcast of the call will be available on the Investors section of the Voyager website at\u00a0ir.voyagertherapeutics.com, and a replay of the call will be available at the same link approximately two hours after its completion. The replay will be available for at least 30 days following the conclusion of the call. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821116","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2024 financial and operating results after market close on Tuesday, March 11, 2025. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET. A live webcast of the call will be available on the Investors section of the Voyager website at\u00a0ir.voyagertherapeutics.com, and a replay of the call will be available at the same link approximately two hours after its completion. The replay will be available for at least 30 days following the conclusion of the call. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to &hellip; Continue reading &quot;Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T12:07:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast\",\"datePublished\":\"2025-03-04T12:07:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/\"},\"wordCount\":266,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/\",\"name\":\"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\",\"datePublished\":\"2025-03-04T12:07:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/","og_locale":"en_US","og_type":"article","og_title":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk","og_description":"LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2024 financial and operating results after market close on Tuesday, March 11, 2025. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET. A live webcast of the call will be available on the Investors section of the Voyager website at\u00a0ir.voyagertherapeutics.com, and a replay of the call will be available at the same link approximately two hours after its completion. The replay will be available for at least 30 days following the conclusion of the call. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to &hellip; Continue reading \"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T12:07:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast","datePublished":"2025-03-04T12:07:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/"},"wordCount":266,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/","name":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=","datePublished":"2025-03-04T12:07:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODA5MSM2Nzg4MTU5IzIwMTg4NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-announces-fourth-quarter-2024-conference-call-and-webcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821116"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821116\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}